Pillstats
Rx only · Solution · Topical

Clindamycin Phosphate Topical

Clindamycin Phosphate

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD10AF01
RxCUI (US)2582
US makers2 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.085$0.169$0.254$0.339Dec 2025Apr 2026Jul 2026
$0.281
Latest avg · Jul 22, 2026
-0%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7.6K15K23K31K2025 Q32025 Q42026 Q1
26K
Rx · 2026 Q1
1.6M
Units dispensed
3
Quarters · since 2025 Q3

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Carnegie Pharmaceuticals LLCunknown2SUPPLYING
i3 Pharmaceuticals, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.